Sulfonylurea drug use lead to elevated IL-12 serum levels in type-2 diabetics, induced by peripheral insulin resistance and beta cell dysfunction, as expressed by fasting serum proinsulin levels. This evidence concerns the gene INS and Insulin resistance.